Sergio A. Quezada
Cancer Research UK · 392 works · 37,962 citations · h-index 83
Top works
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
- Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism
- Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
- Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- CD40/CD154 Interactions at the Interface of Tolerance and Immunity
- Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report
- Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
- Lung adenocarcinoma promotion by air pollutants
- Neoantigen-directed immune escape in lung cancer evolution
- Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
- Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma